United States of America
Anand Mehra, M.D., has served as a member of Aclaris Therapeutics’ board of directors since September 2014. Dr. Mehra joined Sofinnova Ventures, a venture capital firm, in 2007 and currently serves as a general partner. Prior to joining Sofinnova Ventures, Dr. Mehra worked in J.P. Morgan's private equity and venture capital group, and before that, Dr. Mehra was a consultant in McKinsey & Company's pharmaceutical practice. Dr. Mehra currently serves on the boards of directors of Spark Therapeutics, Inc., First Aid Beverages, Inc., and Merus N.V. Dr. Mehra received his Bachelor of Arts in Political Philosophy from the University of Virginia and a Doctor of Medicine from Columbia University's College of Physicians and Surgeons.
Host defense mechanisms,LPS effects on neurotransmitters